Susquehanna International Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $234M | Sell |
475,900
-128,900
| -21% | -$70M | 0.03% | 459 |
|
|
2025
Q4 | $350M | Sell |
604,800
-331,000
| -35% | -$187M | 0.04% | 354 |
|
|
2025
Q3 | $454M | Buy |
935,800
+408,600
| +78% | +$190M | 0.05% | 288 |
|
|
2025
Q2 | $214M | Buy |
527,200
+126,800
| +32% | +$53M | 0.03% | 439 |
|
|
2025
Q1 | $199M | Sell |
400,400
-175,500
| -30% | -$95.1M | 0.03% | 391 |
|
|
2024
Q4 | $300M | Sell |
575,900
-177,200
| -24% | -$97.4M | 0.05% | 314 |
|
|
2024
Q3 | $466M | Buy |
753,100
+289,200
| +62% | +$171M | 0.08% | 207 |
|
|
2024
Q2 | $257M | Sell |
463,900
-77,300
| -14% | -$44.3M | 0.05% | 287 |
|
|
2024
Q1 | $315M | Sell |
541,200
-359,300
| -40% | -$202M | 0.05% | 279 |
|
|
2023
Q4 | $478M | Buy |
900,500
+205,300
| +30% | +$99.4M | 0.09% | 175 |
|
|
2023
Q3 | $352M | Buy |
695,200
+198,200
| +40% | +$106M | 0.07% | 210 |
|
|
2023
Q2 | $259M | Sell |
497,000
-256,500
| -34% | -$138M | 0.05% | 279 |
|
|
2023
Q1 | $434M | Buy |
753,500
+130,500
| +21% | +$73.6M | 0.09% | 169 |
|
|
2022
Q4 | $343M | Buy |
623,000
+2,600
| +0.4% | +$1.38M | 0.09% | 203 |
|
|
2022
Q3 | $315M | Buy |
620,400
+272,900
| +79% | +$153M | 0.08% | 183 |
|
|
2022
Q2 | $189M | Buy |
347,500
+300
| +0.1% | +$165K | 0.05% | 320 |
|
|
2022
Q1 | $205M | Sell |
347,200
-192,300
| -36% | -$110M | 0.04% | 392 |
|
|
2021
Q4 | $360M | Sell |
539,500
-9,000
| -2% | -$5.62M | 0.05% | 291 |
|
|
2021
Q3 | $318M | Buy |
548,500
+56,400
| +11% | +$31M | 0.04% | 356 |
|
|
2021
Q2 | $250M | Sell |
492,100
-2,700
| -0.5% | -$1.27M | 0.04% | 416 |
|
|
2021
Q1 | $226M | Sell |
494,800
-39,000
| -7% | -$18.6M | 0.04% | 411 |
|
|
2020
Q4 | $249M | Buy |
533,800
+308,200
| +137% | +$145M | 0.04% | 361 |
|
|
2020
Q3 | $99.6M | Buy |
225,600
+34,300
| +18% | +$14.2M | 0.02% | 568 |
|
|
2020
Q2 | $69.3M | Sell |
191,300
-101,500
| -35% | -$34M | 0.02% | 656 |
|
|
2020
Q1 | $83M | Buy |
292,800
+139,300
| +91% | +$43.9M | 0.03% | 463 |
|
|
2019
Q4 | $49.9M | Sell |
153,500
-64,400
| -30% | -$19.5M | 0.01% | 808 |
|
|
2019
Q3 | $63.5M | Sell |
217,900
-26,900
| -11% | -$7.7M | 0.02% | 623 |
|
|
2019
Q2 | $71.9M | Buy |
244,800
+94,300
| +63% | +$26M | 0.03% | 527 |
|
|
2019
Q1 | $41.2M | Sell |
150,500
-131,800
| -47% | -$32.8M | 0.02% | 731 |
|
|
2018
Q4 | $63.2M | Buy |
282,300
+73,700
| +35% | +$17.3M | 0.03% | 518 |
|
|
2018
Q3 | $50.9M | Buy |
208,600
+2,400
| +1% | +$552K | 0.02% | 702 |
|
|
2018
Q2 | $42.7M | Sell |
206,200
-73,500
| -26% | -$15.6M | 0.01% | 767 |
|
|
2018
Q1 | $57.7M | Buy |
279,700
+56,100
| +25% | +$11.8M | 0.02% | 602 |
|
|
2017
Q4 | $42.5M | Buy |
223,600
+14,400
| +7% | +$2.76M | 0.02% | 776 |
|
|
2017
Q3 | $39.6M | Buy |
209,200
+9,500
| +5% | +$1.72M | 0.02% | 756 |
|
|
2017
Q2 | $34.8M | Buy |
199,700
+37,200
| +23% | +$6.25M | 0.02% | 798 |
|
|
2017
Q1 | $25M | Buy |
162,500
+42,200
| +35% | +$6.45M | 0.01% | 926 |
|
|
2016
Q4 | $17M | Sell |
120,300
-167,700
| -58% | -$24.7M | 0.01% | 1166 |
|
|
2016
Q3 | $45.8M | Sell |
288,000
-227,900
| -44% | -$35.1M | 0.02% | 591 |
|
|
2016
Q2 | $76.2M | Buy |
515,900
+290,100
| +128% | +$42.8M | 0.04% | 376 |
|
|
2016
Q1 | $32M | Sell |
225,800
-98,200
| -30% | -$13.2M | 0.02% | 717 |
|
|
2015
Q4 | $46M | Sell |
324,000
-5,800
| -2% | -$774K | 0.02% | 642 |
|
|
2015
Q3 | $40.3M | Sell |
329,800
-111,500
| -25% | -$14.5M | 0.02% | 746 |
|
|
2015
Q2 | $57.3M | Buy |
441,300
+79,600
| +22% | +$10.4M | 0.02% | 623 |
|
|
2015
Q1 | $48.6M | Sell |
361,700
-10,600
| -3% | -$1.37M | 0.02% | 652 |
|
|
2014
Q4 | $46.6M | Buy |
372,300
+30,000
| +9% | +$3.65M | 0.02% | 760 |
|
|
2014
Q3 | $41.7M | Sell |
342,300
-327,000
| -49% | -$39.8M | 0.02% | 847 |
|
|
2014
Q2 | $79M | Sell |
669,300
-53,200
| -7% | -$6.26M | 0.03% | 464 |
|
|
2014
Q1 | $86.9M | Buy |
722,500
+504,800
| +232% | +$60M | 0.04% | 394 |
|
|
2013
Q4 | $24.2M | Sell |
217,700
-93,600
| -30% | -$9.31M | 0.01% | 1166 |
|
|
2013
Q3 | $28.7M | Buy |
311,300
+41,800
| +16% | +$3.78M | 0.02% | 942 |
|
|
2013
Q2 | $22.8M | Buy |
+269,500
| New | +$22.4M | 0.01% | 1024 |
|
Other funds holding TMO
VCM
Susquehanna International Group's TMO Position: Q1 2026 in Review
Susquehanna International Group reduced its Thermo Fisher Scientific (TMO) stake by 67% in Q1 2026, selling an estimated $70.1M and leaving 64,399 shares worth $31.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1681.
Susquehanna International Group first reported a position in TMO in Q2 2013 and has held it in 47 quarters since. The position peaked at $144M in Q4 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Susquehanna International Group held 64,399 shares of Thermo Fisher Scientific worth $31.7M as of Q1 2026.
- Susquehanna International Group sold 129,156 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.1M.
- Thermo Fisher Scientific made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1681 holding.
- Susquehanna International Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Thermo Fisher Scientific position peaked at $144M in Q4 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.